Michael Waxman, MD
Emergency Medicine · Providence, RINPI 1518904481
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $73,421 of the $73,697 with a category attached, or 99.6%. Gilead accounts for 99.9% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2020 at $27,485 and has fallen 99.3% since, to $184 in 2023. Among emergency medicine clinicians in RI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 11 payments — averaging $6699.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$74K
- Vapotherm Inc$41
Across 10 payments — averaging $9064.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gen-probe, Inc.$91K
What the payments were for
- Consulting fees$73,421100%
- Food & beverage$2760%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 10 | $73,657 |
| Vapotherm Inc | 1 | $41 |
How this compares
$73,697 in reported general payments places this provider in the 95th percentile of 286 emergency medicine providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 18 | $4,944 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Providence
- Francesca BeaudoinProvidence$20K
- Arun NagdevProvidence$16K
- Roland MerchantProvidence$15K
- Eliot JekowskyProvidence$10K
- Jeremiah SchuurProvidence$4K
- Megan RanneyProvidence$3K
- Kristina McAteerProvidence$3K
- Amie WoodsProvidence$2K
- Robert PartridgeProvidence$2K
- Jessica SmithProvidence$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.